By Iain Gilbert
Date: Friday 07 Mar 2025
(Sharecast News) - Life sciences firm Avacta revealed on Friday that it has agreed to sell its UK-based diagnostics unit to Duomed Belgium for £12.9m in cash.
Avacta said the sale of Launch Diagnostics and its subsidiaries was expected to be completed by the end of April 2025, subject to customary...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news